Facebook Linkedin Twitter
Inside Precision Medicine Takeda, Jounce Drug Candidate Mobilizes Immunity by Suppressing SUMOylation

Interferons

3d illustration proteins with lymphocytes , t cells or cancer cells
News & Features

Takeda, Jounce Drug Candidate Mobilizes Immunity by Suppressing SUMOylation

Anjali A. Sarkar, PhD -
0
Cell division in 3D organoids
News & Features

Drug Activation of p53 Protein Boosts Anti-Tumor Immune Response

Helen Albert -
0
coronavirs
Coronavirus

Sussing Out COVID-19 Severity

Helen Albert -
0
Coronavirus structure
Coronavirus

Interferon-Stimulated Genes Limit SARS-CoV-2 Infection

Malorye Branca -
0
Leprosy Drug Shows Potential as At-Home Treatment for COVID-19
Coronavirus

Leprosy Drug Shows Potential as At-Home Treatment for COVID-19

Inside Precision Medicine Staff Writer -
0
USA, New Jersey, Portrait of man with down syndrome
Coronavirus

Genetic Factors of Down Syndrome Influence COVID-19 Outcomes

Chris Anderson -
0
Microbiotica will use its precision metagenomics microbiome platform in an up-to-$534 million-plus partnership with Genentech
News & Features

Specific Gut Microbes that Trigger Immune Response to Viral Infections Identified

Sophia Ktori -
0
Human interferon alpha molecule
Coronavirus

Compromised Type I Interferon Response Common Among Severe COVID-19 Patients

Inside Precision Medicine Staff Writer -
0
Services that include continuous remote access to tumor specialists and treatment navigators will be made available to community hospitals
News & Features

STING Activation Touted as Potential Immunotherapy for Cancer

Inside Precision Medicine Staff Writer -
0
remdesivir covid-19 liquid medication background
Coronavirus

NIH Launches Remdesivir Plus Interferon Beta-1a Trial for COVID-19 Treatment

Chris Anderson -
0
123Page 2 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine